Month: April 2020

INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference


Excerpt from the press release: “PLYMOUTH MEETING, Pa. and SEOUL, South Korea, April 28, 2020 /PRNewswire/ — INOVIO (NASDAQ:INO) and GeneOne Life Science (KSE:011000) today announced interim data through week 16 from a Phase 1/2a trial of DNA vaccine INO-4700 (also called GLS-5300) for MERS coronavirus (MERS-CoV). Vaccine recipients demonstrated strong antibody and T cell immune…

Read More

How BlueDot spots warning signs of pandemics


Excerpt from the article: “When it comes to viral outbreaks, every day is valuable: stopping a pandemic means getting the right information to the right people at the right time. BlueDot identified the emerging risk of COVID-19 in Hubei province eight days before the World Health Organization.” Click the button below to read the entire…

Read More

Vaxart Plans to Push COVID-19 Vaccine Candidate into the Clinic


Excerpt From the Article: Bay Area-based Vaxart, Inc. has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. Now, the company plans to push one or more into the clinic. Sean Tucker, Vaxart’s chief scientific officer, said the…

Read More

Low-dose CT works well for COVID-19 assessment


Excerpt from the article: April 23, 2020 — Chest CT at a radiation dose under 1 mSv can accurately and rapidly assess COVID-19 infection in emergency room patients — particularly those who have had symptoms longer than 48 hours, according to a study published April 21 in Radiology: Cardiothoracic Imaging. The results are good news…

Read More

This sensor could detect COVID-19 in the air


Excerpt From the Article: Researchers at the Swiss Federal Laboratory have developed a sensor that could potentially quickly and reliably detect SARS-CoV-2, the COVID-19 virus. Prior to the coronavirus spreading around the world, Jing Wang and his colleagues were researching sensors that could detect bacteria and viruses in the air. The concept of the sensor…

Read More

Anyone with a computer can help this Covid-19 project


Excerpt from the article: The Washington University School of Medicine’s Folding@home project will utilise supercomputers at the Science and Technology Facilities Council (STFC) Hartree Centre to better understand protein behaviour in diseases. The project is calling on anyone with a personal computer to help out, as they can lend any unused background capacity to help…

Read More

Building a bridge to a COVID-19 vaccine


Excerpt from the article: Regeneron has shared high hopes for its two candidates in the fight against COVID-19 on the first day of the four-day eyeforpharma Philadelphia virtual event. George Yancopolous, President and Chief Scientific Officer at Regeneron, revealed that the company expected to have a good idea of the prospects for Kevzara, one…

Read More

COVID-19 funding opportunities


Excerpt from the article: Innovative Solutions Canada has dedicated funding to help combat current and future outbreaks of the novel coronavirus (COVID-19) and other similar threats. Our program will help support the Government of Canada’s fight against COVID-19 by funding R&D and testing prototypes in real-life settings that can help protect Canadians. Click the button…

Read More

How Mapping COVID-19 Could Help Drug Companies


Excerpt from the article: When the spread of COVID-19 started to affect the University of Connecticut, the state, and the country, Ranjan Srivastava, department head for Chemical and Biomolecular Engineering, knew he had to spring into action. Drawing on his previous work in mathematically modeling how the Hepatitis B virus spreads, Srivastava realized he could…

Read More

UPMC led global trial fast tracks testing of hydroxychloroquine, other COVID-19 therapies


Excerpt from the article: PITTSBURGH, April 9, 2020 – A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched today at UPMC to address one of the most important debates during the COVID-19 pandemic: How should doctors decide between quickly adopting new therapies, such as the anti-malarial drug hydroxychloroquine,…

Read More